Feedback / Questions
resiquimod SR (TransCon TLR7/8 Agonist) - Ascendis
Keytruda (pembrolizumab) - Merck (MSD)
http://clinicaltrials.gov/ct2/show/NCT04799054
Jun 5, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next